{"id":57697,"date":"2026-02-24T15:43:54","date_gmt":"2026-02-24T07:43:54","guid":{"rendered":"https:\/\/flcube.com\/?p=57697"},"modified":"2026-02-24T15:43:55","modified_gmt":"2026-02-24T07:43:55","slug":"merck-restructures-human-health-into-oncology-and-specialty-units-appoints-oosthuizen-and-foard-to-lead-new-divisions","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=57697","title":{"rendered":"Merck Restructures Human Health into Oncology and Specialty Units \u2013 Appoints Oosthuizen and Foard to Lead New Divisions"},"content":{"rendered":"\n<p><strong>Merck &amp; Co. (MSD, <a href=\"https:\/\/www.google.com\/finance\/quote\/MRK:NYSE\">NYSE:\u202fMRK<\/a>)<\/strong> announced a major organizational restructuring of its <strong>Human Health<\/strong> division, splitting the business into two distinct units: an <strong>Oncology Business Unit<\/strong> and a <strong>Specialty, Pharma &amp; Infectious Diseases Business Unit<\/strong>. The move aims to sustain long\u2011term leadership in oncology while sharpening focus on a growing pipeline of launches across an increasingly diversified portfolio.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-organizational-restructuring\">Organizational Restructuring<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Merck &amp; Co. (MSD, NYSE:\u202fMRK)<\/td><\/tr><tr><td><strong>Announcement Date<\/strong><\/td><td>23\u202fFeb\u202f2026<\/td><\/tr><tr><td><strong>New Structure<\/strong><\/td><td>Two Business Units replacing unified Human Health organization<\/td><\/tr><tr><td><strong>Unit 1<\/strong><\/td><td>Oncology Business Unit<\/td><\/tr><tr><td><strong>Unit 2<\/strong><\/td><td>Specialty, Pharma &amp; Infectious Diseases Business Unit<\/td><\/tr><tr><td><strong>Reporting Line<\/strong><\/td><td>Both presidents report to Robert M. Davis, Chairman &amp; CEO<\/td><\/tr><tr><td><strong>Strategic Goal<\/strong><\/td><td>Sustain oncology leadership + accelerate diverse portfolio launches<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-leadership-appointments\">Leadership Appointments<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-jannie-oosthuizen-president-oncology-amp-msd-international\">Jannie Oosthuizen \u2013 President, Oncology &amp; MSD International<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>New Role:<\/strong> Executive Vice President and President, Oncology Business Unit and MSD International<\/li>\n\n\n\n<li><strong>Previous Role:<\/strong> Senior Vice President and President, MSD Human Health U.S.<\/li>\n\n\n\n<li><strong>Responsibilities:<\/strong> P&amp;L oversight, strategy, and commercialization for oncology portfolio; international operations<\/li>\n\n\n\n<li><strong>Background:<\/strong> Extensive global marketing expertise with proven commercial results in oncology markets worldwide<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-brian-foard-president-specialty-pharma-amp-infectious-diseases\">Brian Foard \u2013 President, Specialty, Pharma &amp; Infectious Diseases<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>New Role:<\/strong> Executive Vice President and President, Specialty, Pharma &amp; Infectious Diseases Business Unit<\/li>\n\n\n\n<li><strong>Start Date:<\/strong> 2\u202fMar\u202f2026<\/li>\n\n\n\n<li><strong>Previous Role:<\/strong> Executive Vice President and Head of Specialty Care Business Unit, Sanofi<\/li>\n\n\n\n<li><strong>Portfolio Oversight at Sanofi:<\/strong> Immunology, neurology, oncology, and rare diseases<\/li>\n\n\n\n<li><strong>Prior Experience:<\/strong> Nearly two decades at Galderma (dermatology specialist), with progressive U.S. and global leadership roles<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale-amp-pipeline-outlook\">Strategic Rationale &amp; Pipeline Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Oncology Focus:<\/strong> The dedicated Oncology Business Unit positions Merck to defend and extend its leadership in the <strong>Keytruda\u2011dominated<\/strong> immuno\u2011oncology market, while capitalizing on next\u2011generation pipeline assets.<\/li>\n\n\n\n<li><strong>Diversification Drive:<\/strong> The Specialty, Pharma &amp; Infectious Diseases unit will manage a broadening portfolio spanning <strong>vaccines, infectious diseases, cardiometabolic, and specialty therapeutics<\/strong>\u2014reducing reliance on oncology revenue concentration.<\/li>\n\n\n\n<li><strong>Late\u2011Stage Pipeline:<\/strong> Merck is conducting approximately <strong>80 Phase\u202f3 studies<\/strong>, with expectations of <strong>20+ new growth drivers<\/strong> over the coming years, almost all with <strong>blockbuster potential<\/strong>.<\/li>\n\n\n\n<li><strong>Commercial Execution:<\/strong> The bifurcated structure enables tailored go\u2011to\u2011market strategies\u2014focused oncology expertise for complex cancer therapies, and specialized capabilities for diverse specialty and primary care launches.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact\">Market Impact<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Investor Signal:<\/strong> The restructuring signals Merck\u2019s confidence in its <strong>non\u2011oncology pipeline<\/strong> and intent to build sustainable diversification beyond Keytruda\u2019s patent lifecycle.<\/li>\n\n\n\n<li><strong>Talent Acquisition:<\/strong> The recruitment of <strong>Brian Foard from Sanofi<\/strong> brings deep specialty care commercial experience, complementing <strong>Oosthuizen\u2019s<\/strong> proven oncology track record.<\/li>\n\n\n\n<li><strong>Competitive Positioning:<\/strong> As peers navigate post\u2011pandemic portfolio transitions, Merck\u2019s organizational clarity may provide operational agility in capturing market share across multiple therapeutic areas.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding organizational changes, pipeline potential, and commercial expectations. Actual results may differ due to risks including pipeline attrition, competitive dynamics, and integration challenges.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Merck &amp; Co. (MSD, NYSE:\u202fMRK) announced a major organizational restructuring of its Human Health division,&#8230;<\/p>\n","protected":false},"author":1,"featured_media":57710,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[120,176,903],"class_list":["post-57697","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","tag-merck","tag-msd","tag-nyse-mrk"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Merck Restructures Human Health into Oncology and Specialty Units \u2013 Appoints Oosthuizen and Foard to Lead New Divisions - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Merck &amp; Co. (MSD, NYSE:\u202fMRK) announced a major organizational restructuring of its Human Health division, splitting the business into two distinct units: an Oncology Business Unit and a Specialty, Pharma &amp; Infectious Diseases Business Unit. The move aims to sustain long\u2011term leadership in oncology while sharpening focus on a growing pipeline of launches across an increasingly diversified portfolio.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=57697\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck Restructures Human Health into Oncology and Specialty Units \u2013 Appoints Oosthuizen and Foard to Lead New Divisions\" \/>\n<meta property=\"og:description\" content=\"Merck &amp; Co. (MSD, NYSE:\u202fMRK) announced a major organizational restructuring of its Human Health division, splitting the business into two distinct units: an Oncology Business Unit and a Specialty, Pharma &amp; Infectious Diseases Business Unit. The move aims to sustain long\u2011term leadership in oncology while sharpening focus on a growing pipeline of launches across an increasingly diversified portfolio.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=57697\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-24T07:43:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T07:43:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2401.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57697#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57697\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Merck Restructures Human Health into Oncology and Specialty Units \u2013 Appoints Oosthuizen and Foard to Lead New Divisions\",\"datePublished\":\"2026-02-24T07:43:54+00:00\",\"dateModified\":\"2026-02-24T07:43:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57697\"},\"wordCount\":482,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57697#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/2401.webp\",\"keywords\":[\"Merck\",\"MSD\",\"NYSE: MRK\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=57697#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57697\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=57697\",\"name\":\"Merck Restructures Human Health into Oncology and Specialty Units \u2013 Appoints Oosthuizen and Foard to Lead New Divisions - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57697#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57697#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/2401.webp\",\"datePublished\":\"2026-02-24T07:43:54+00:00\",\"dateModified\":\"2026-02-24T07:43:55+00:00\",\"description\":\"Merck & Co. (MSD, NYSE:\u202fMRK) announced a major organizational restructuring of its Human Health division, splitting the business into two distinct units: an Oncology Business Unit and a Specialty, Pharma & Infectious Diseases Business Unit. The move aims to sustain long\u2011term leadership in oncology while sharpening focus on a growing pipeline of launches across an increasingly diversified portfolio.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57697#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=57697\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57697#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/2401.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/2401.webp\",\"width\":1080,\"height\":608,\"caption\":\"Merck Restructures Human Health into Oncology and Specialty Units \u2013 Appoints Oosthuizen and Foard to Lead New Divisions\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=57697#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck Restructures Human Health into Oncology and Specialty Units \u2013 Appoints Oosthuizen and Foard to Lead New Divisions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Merck Restructures Human Health into Oncology and Specialty Units \u2013 Appoints Oosthuizen and Foard to Lead New Divisions - Insight, China&#039;s Pharmaceutical Industry","description":"Merck & Co. (MSD, NYSE:\u202fMRK) announced a major organizational restructuring of its Human Health division, splitting the business into two distinct units: an Oncology Business Unit and a Specialty, Pharma & Infectious Diseases Business Unit. The move aims to sustain long\u2011term leadership in oncology while sharpening focus on a growing pipeline of launches across an increasingly diversified portfolio.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=57697","og_locale":"en_US","og_type":"article","og_title":"Merck Restructures Human Health into Oncology and Specialty Units \u2013 Appoints Oosthuizen and Foard to Lead New Divisions","og_description":"Merck & Co. (MSD, NYSE:\u202fMRK) announced a major organizational restructuring of its Human Health division, splitting the business into two distinct units: an Oncology Business Unit and a Specialty, Pharma & Infectious Diseases Business Unit. The move aims to sustain long\u2011term leadership in oncology while sharpening focus on a growing pipeline of launches across an increasingly diversified portfolio.","og_url":"https:\/\/flcube.com\/?p=57697","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-02-24T07:43:54+00:00","article_modified_time":"2026-02-24T07:43:55+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2401.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=57697#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=57697"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Merck Restructures Human Health into Oncology and Specialty Units \u2013 Appoints Oosthuizen and Foard to Lead New Divisions","datePublished":"2026-02-24T07:43:54+00:00","dateModified":"2026-02-24T07:43:55+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=57697"},"wordCount":482,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=57697#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2401.webp","keywords":["Merck","MSD","NYSE: MRK"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=57697#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=57697","url":"https:\/\/flcube.com\/?p=57697","name":"Merck Restructures Human Health into Oncology and Specialty Units \u2013 Appoints Oosthuizen and Foard to Lead New Divisions - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=57697#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=57697#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2401.webp","datePublished":"2026-02-24T07:43:54+00:00","dateModified":"2026-02-24T07:43:55+00:00","description":"Merck & Co. (MSD, NYSE:\u202fMRK) announced a major organizational restructuring of its Human Health division, splitting the business into two distinct units: an Oncology Business Unit and a Specialty, Pharma & Infectious Diseases Business Unit. The move aims to sustain long\u2011term leadership in oncology while sharpening focus on a growing pipeline of launches across an increasingly diversified portfolio.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=57697#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=57697"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=57697#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2401.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2401.webp","width":1080,"height":608,"caption":"Merck Restructures Human Health into Oncology and Specialty Units \u2013 Appoints Oosthuizen and Foard to Lead New Divisions"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=57697#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Merck Restructures Human Health into Oncology and Specialty Units \u2013 Appoints Oosthuizen and Foard to Lead New Divisions"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/02\/2401.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/57697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=57697"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/57697\/revisions"}],"predecessor-version":[{"id":57711,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/57697\/revisions\/57711"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/57710"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=57697"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=57697"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=57697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}